Please login to the form below

Not currently logged in
Email:
Password:

Polleo Pharma co-founders join Chronos Therapeutics

Dr Fraser Murray and Dr Timonthy Schulz-Utermoehl become pre-clinical development VPs

Chronos Dr Fraser MurrayOxford, UK-based Chronos Therapeutics has appointed Dr Fraser Murray and Dr Timothy Schulz-Utermoehl as vice presidents of pre-clinical development.

Together, they will oversee three pre-clinical research programmes recently acquired by the privately-held biotech, which target fatigue in multiple sclerosis, addictive behaviours and post-traumatic stress disorder, respectively.

Dr Murray (pictured above) brings over 20 years of drug discovery and early development experience to the role, spread across a range of therapeutic areas including dermatology, inflammation, neurodegeneration, psychiatry.

Prior to co-founding Polleo Pharma in 2014, Dr Murray served as senior director and head of discovery biology for Shire Specialty Pharmaceuticals, with a focus on central nervous system and gastrointestinal disorders.

He has also held a number of leadership roles at AstraZeneca, Calcico Therapeutics and Merck & Co.

Chronos Dr Timothy Schulz-UtermoehlMeanwhile, Dr Schulz-Utermoehl (pictured left) brings 17 years of early- and late-stage discovery research and preclinical development expertise to Chronos.

As well as co-founding Polleo Pharma alongside Dr Murray, he has worked at AstraZeneca, Merck & Co, Novo Nordisk and, most recently, Shire, where he served as a director in its exploratory projects department in the UK.

Chief executive officer of Chronos Dr Huw Jones said: “We are delighted to welcome Fraser and Timothy to Chronos at a time of significant expansion of our research portfolio.

“They bring substantial pre-clinical development expertise to our organisation and are synergistic to our recent acquisition.
“In particular, their experience as co-founders of Polleo will be invaluable as we advance our behavioural brain disease portfolio.”

4th August 2016

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics